Abstract

Aim: Patent ductus arteriosus (PDA), a cause of significant hemodynamic imbalance in newborn babies, can be treated using pharmacological or surgical methods. The purpose of this study was to compare intravenous (IV) paracetamol in newborns with hemodynamically significant PDA, with indomethacin and ibuprofen in terms of changes caused in blood parameters.

Methods: Intravenous paracetamol was used for 3-6 days at 4x15 mg/kg/dose in cases diagnosed with PDA and admitted for follow-up between November 2014 and December 2015, and unable to receive oral medication or with contraindications for indomethacin-ibuprofen use. These cases were investigated retrospectively in terms of changes in pre and post-treatment AST (aspartate aminotransferase), ALT (alanine aminotransferase), urea, creatinine, platelet, and neutrophil values.

Results: Intravenous paracetamol was administered to 10 cases of PDA, diagnosed between November 2014 and December 2015. Prior to paracetamol therapy, an increase in urea values was present in one case, increased AST in two, and decreased platelet values in two. Post-treatment values returned to normal ranges in all cases, and hemodynamic improvement was observed after the closure of the ductus arteriosus.

Conclusion: Our analysis of its effect on PDA closure and its potential side-effect profile in patient blood parameters compared to other known therapeutic agents indicates that intravenous paracetamol, which is easily available and accessible in Turkey, may be an important option for the treatment of PDA.

Keywords: Patent ductus arteriosus, paracetamol, blood parameter, preterm, treatment

Copyright and license

Copyright © 2023 The Author(s). This is an open-access article published by Bolu İzzet Baysal Training and Research Hospital under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Kaya Dinçel G, Dilek M, Bekdaş M, Sancak S, Kabakuş N. The effects of intravenous paracetamol use on blood parameters in the treatment of patent ductus arteriosus. Northwestern Med J. 2023;3(1):9-15. https://doi.org/10.54307/NWMJ.2023.55265

References

  1. Linder N, Bello R, Hernandez A, et al. Treatment of patent ductus arteriosus: indomethacin or ibuprofen? Am J Perinatol. 2010; 27(5): 399-404. https://doi.org/10.1055/s-0029-1243315
  2. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010; 2010(7): CD000174. https://doi.org/10.1002/14651858.CD000174.pub2
  3. Allegaert K, Anderson B, Simons S, van Overmeire B. Paracetamol to induce ductus arteriosus closure: is it valid? Arch Dis Child. 2013; 98(6): 462-6. https://doi.org/10.1136/archdischild-2013-303688
  4. Oncel MY, Yurttutan S, Degirmencioglu H, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology. 2013; 103(3): 166-9. https://doi.org/10.1159/000345337
  5. Chorne N, Leonard C, Piecuch R, Clyman RI. Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics. 2007; 119(6): 1165-74. https://doi.org/10.1542/peds.2006-3124
  6. Baylen BG, Ogata H, Ikegami M, Jacobs HC, Jobe AH, Emmanouilides GC. Left ventricular performance and regional blood flows before and after ductus arteriosus occlusion in premature lambs treated with surfactant. Circulation. 1983; 67(4): 837-43. https://doi.org/10.1161/01.cir.67.4.837
  7. Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr. 2005; 164(3): 135-40. https://doi.org/10.1007/s00431-004-1596-5
  8. Köksal N, Aygün C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars. 2018; 53(Suppl 1): S76-87. https://doi.org/10.5152/TurkPediatriArs.2018.01808
  9. Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Rev. 2013; (4): CD003481; . https://doi.org/10.1002/14651858.cd003481.pub5
  10. Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2020; 1(1): CD010061. https://doi.org/10.1002/14651858.CD010061.pub4
  11. Gokmen T, Erdeve O, Altug N, Oguz SS, Uras N, Dilmen U. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr. 2011; 158(4): 549-554.e1. https://doi.org/10.1016/j.jpeds.2010.10.008
  12. Terrin G, Conte F, Oncel MY, et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2016; 101(2): F127-36. https://doi.org/10.1136/archdischild-2014-307312
  13. Clyman RI, Seidner SR, Kajino H, et al. VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus. Am J Physiol Regul Integr Comp Physiol. 2002; 282(1): R199-206. https://doi.org/10.1152/ajpregu.00298.2001
  14. Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV, Clyman RI. Combined treatment with a nonselective nitric oxide synthase inhibitor (l-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res. 2005; 58(6): 1216-21. https://doi.org/10.1203/01.pdr.0000183659.20335.12
  15. Siassi B, Blanco C, Cabal LA, Coran AG. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants. Pediatrics. 1976; 57(3): 347-51.
  16. Fanaroff AA. Principles of neonatal cardiovascular hemodynamics in neonatal perinatal medicine. 7th ed. 2002: 1138-40.
  17. Stoller JZ, Epstein JA. Cardiac neural crest. Semin Cell Dev Biol. 2005; 16(6): 704-15. https://doi.org/10.1016/j.semcdb.2005.06.004
  18. Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics. 2011; 128(6): e1618-21. https://doi.org/10.1542/peds.2011-0359
  19. Valerio E, Valente MR, Salvadori S, Frigo AC, Baraldi E, Lago P. Intravenous paracetamol for PDA closure in the preterm: a single-center experience. Eur J Pediatr. 2016; 175(7): 953-66. https://doi.org/10.1007/s00431-016-2731-9
  20. Rostas SE, McPherson CC. Pharmacotherapy for Patent Ductus Arteriosus: Current Options and Outstanding Questions. Curr Pediatr Rev. 2016; 12(2): 110-9. https://doi.org/10.2174/157339631202160506002028